triazinate has been researched along with Adenocarcinoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (90.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunner, KW; Cavalli, F; Goldhirsch, A; Joss, RA; Mermillod, B | 1 |
| Arsenau, JC; Blessing, J; Lewis, GC; Slavik, M | 1 |
| Bruckner, HW; Lokich, JJ; Stablein, DM | 1 |
| Bukowski, RM; LoBuglio, A; McCracken, J; Pugh, R | 1 |
| Cullinan, SA; Krook, JE; Mailliard, JA; Moertel, CG; O'Connell, MJ; Poon, MA; Tschetter, LK; Wieand, HS | 1 |
| Banner, RL; Benjamin, RS; Bodey, GP; Burgess, MA; Freireich, EJ; Gutterman, JU; Murphy, WK; Richman, SP; Rodriguez, V; Valdivieso, M | 1 |
| Frytak, S; Hahn, RG; McCreary, RH; Moertel, CG; O'Connell, MJ; Reitemeier, RJ; Rubin, J; Schutt, AJ | 1 |
| Benjamin, RS; Bodey, GP; Burgess, MA; Hall, SW; Loo, TL; Tenczynski, TF; Valdivieso, M | 1 |
| Hahn, RG; Moertel, CG; O'Connell, MJ; Schutt, AJ | 1 |
| Ahlgren, JD; Cazap, E; Estevez, RA; Marantz, A; Schein, PS; Smith, FP; Stein, J; Wilcosky, T; Woolley, PV | 1 |
1 review(s) available for triazinate and Adenocarcinoma
| Article | Year |
|---|---|
New agents in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Indazoles; Lung Neoplasms; Male; Mice; Mitoxantrone; Triazines; Vinblastine; Vindesine | 1984 |
4 trial(s) available for triazinate and Adenocarcinoma
| Article | Year |
|---|---|
New agents in non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Alkylating Agents; Animals; Anthraquinones; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Clinical Trials as Topic; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Indazoles; Lung Neoplasms; Male; Mice; Mitoxantrone; Triazines; Vinblastine; Vindesine | 1984 |
Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. North Central Cancer Treatment Group.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Female; Fluorouracil; Humans; Lomustine; Male; Middle Aged; Stomach Neoplasms; Survival Analysis; Treatment Outcome; Triazines | 1994 |
Clinical, toxicological, and pharmacological studies of combination chemotherapy of adenocarcinoma with adriamycin and Baker's antifolate.
Topics: Adenocarcinoma; Adult; Aged; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Female; Folic Acid Antagonists; Gastrointestinal Neoplasms; Humans; Kinetics; Lung Neoplasms; Male; Middle Aged; Triazines | 1978 |
FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Doxorubicin; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Stomach Neoplasms; Triazines | 1987 |
6 other study(ies) available for triazinate and Adenocarcinoma
| Article | Year |
|---|---|
Phase II studies in advanced, recurrent pelvic malignancies: conducted by the Gynecologic Oncology Group, Experimental Design and Experience.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Dianhydrogalactitol; Drug Evaluation; Etoposide; Female; Humans; Maytansine; Neoplasm Recurrence, Local; Pelvic Neoplasms; Piperazines; Razoxane; Research Design; Triazines | 1982 |
Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.
Topics: Adenocarcinoma; Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Humans; Male; Methotrexate; Middle Aged; Myeloproliferative Disorders; Prognosis; Random Allocation; Razoxane; Triazines | 1982 |
Phase II trial of Baker's antifol in metastatic renal cell carcinoma: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Diarrhea; Drug Evaluation; Female; Granulocytes; Humans; Kidney Neoplasms; Leukocyte Count; Male; Middle Aged; Nausea; Platelet Count; Triazines; Vomiting | 1980 |
Phase 2 study with Baker's Antifol in solid tumors.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Carcinoma, Squamous Cell; Colonic Neoplasms; Drug Eruptions; Female; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Kidney Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Rectal Neoplasms; Remission, Spontaneous; Sarcoma; Stomatitis; Triazines | 1977 |
A phase II study of triazinate (NSC 139105) in advanced colorectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Diarrhea; Drug Eruptions; Female; Folic Acid Antagonists; Humans; Immunoglobulins; Leukopenia; Lymphocyte Activation; Male; Middle Aged; Nausea; Rectal Neoplasms; Skin Tests; Stomatitis; Thrombocytopenia; Triazines | 1977 |
Phase II clinical trial of triazinate in combination with mitomycin C for patients with advanced gastric cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Stomach Neoplasms; Triazines | 1987 |